- 产品信息
商品描述
靶点-Target
RAB21
反应性
Human,Rat,Mouse
应用
WB,ELISA
宿主物种-Host Species
Rabbit
同种型-Isotype
IgG
修饰-Modification
Unmodified
MW(Observed)
24kD
推荐稀释比
WB 1:500-2000;ELISA 1:5000-20000
组成
PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
纯化工艺
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
储存
-15°C to -25°C/1 year(Do not lower than -25°C)
浓度
1 mg/ml
克隆性
Polyclonal
免疫原
Synthesized peptide derived from human protein . at AA range: 60-140
特异性
RAB21 Polyclonal Antibody detects endogenous levels of protein.
基因名称
RAB21 KIAA0118
蛋白名称
Ras-related protein Rab-21
Organism-1
Human
基因ID-1
23011
SwissProt-1
Q9UL25
Organism-2
Mouse
SwissProt-2
P35282
Organism-3
Rat
SwissProt-3
Q6AXT5
背景
This gene belongs to the Rab family of monomeric GTPases, which are involved in the control of cellular membrane traffic. The encoded protein plays a role in the targeted trafficking of integrins via its association with integrin alpha tails. As a consequence, the encoded protein is involved in the regulation of cell adhesion and migration. Expression of this gene is associated with a poor prognosis for glioma patients. This gene is downregulated by the tumor suppressor miR-200b, and miRNA-200b is itself downregulated in glioma tissues. [provided by RefSeq, Nov 2015],
细胞定位
Endoplasmic reticulum membrane ; Lipid-anchor . Golgi apparatus, trans-Golgi network . Golgi apparatus membrane . Early endosome membrane . Cytoplasmic vesicle membrane . Cleavage furrow . Cell projection, neuron projection . Colocalizes with ANKRD27 and VAMP7 in neurites (By similarity). In nonpolarized epithelial Caco-2 cells, found in the endoplasmic reticulum; in polarized cells, observed in vesicles in the apical cytoplasm (PubMed:10887961). During mitosis, in mid-telophase, localized in the ingressing cleavage furrow (PubMed:18804435). In late telophase, detected at the opposite poles of the daughter cells, in vesicles at the base of lamellipodia formed by the separating daughter cells (PubMed:18804435). .





